SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-060201
Filing Date
2022-09-29
Accepted
2022-09-29 16:15:31
Documents
12
Period of Report
2022-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea166546-8k_aikidopharma.htm   iXBRL 8-K 26870
  Complete submission text file 0001213900-22-060201.txt   199099

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aiki-20220923.xsd EX-101.SCH 3248
3 XBRL LABEL FILE aiki-20220923_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE aiki-20220923_pre.xml EX-101.PRE 22373
6 EXTRACTED XBRL INSTANCE DOCUMENT ea166546-8k_aikidopharma_htm.xml XML 3595
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 221280740
SIC: 8731 Services-Commercial Physical & Biological Research